Work

Rifaximin, a Nonabsorbed Oral Antibiotic, Prevents Shigellosis after Experimental Challenge

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Infectious Diseases

DOI: 10.1086/503039

Authors: D. N. Taylor, R. McKenzie, A. Durbin, C. Carpenter, C. B. Atzinger, R. Haake, A. L. Bourgeois

Institutions: Johns Hopkins University, Salix Pharmaceuticals (United States)

Language: English

Topic: Salmonella and Campylobacter epidemiology

Subfield: Food Science

Field: Agricultural and Biological Sciences

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Johns Hopkins University, National Institutes of Health, National Center for Research Resources

Awards: G373348672, G9000305379

OpenAlex ID: W2136979506

FWCI: 14.48

Cites: 28

Cited by: 71

Related to: 10